Position in EXEL
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$18,664,207
+$2,683,393 QoQ
Shares Held
343,029
-7.9% QoQ
Ownership
0.138%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#94
of 751 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 80%
Shared 0%
None 20%
Common Shares in EXEL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026LAZARD ASSET MANAGEMENT LLC holds $400,660,289 across 59 Biotechnology names. EXEL ranks #6 (4.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
131,996 | $122,461,928 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
93,287 | $46,338,451 | |
| 3 | ONC |
BeOne Medicines Ltd.
|
90,348 | $25,746,469 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
36,910 | $23,014,861 | |
| 5 | BMRN |
Biomarin Pharmaceutical Inc
|
350,397 | $20,049,716 | |
| 6 | EXEL |
Exelixis, Inc.
This page
|
343,029 | $18,664,207 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
69,588 | $16,768,620 | |
| 8 | INCY |
Incyte Corp
|
136,684 | $15,494,498 |
All Filings in EXEL
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $18,664,207 | 343,029 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $15,980,814 | 372,600 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $14,178,961 | 323,499 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $12,284,065 | 297,435 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $11,558,524 | 262,217 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $9,407,141 | 254,798 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $7,141,583 | 214,462 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $3,091,863 | 119,147 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $1,284,676 | 57,173 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $891,179 | 37,555 | Shares | Sole | 2024-07-09 | |
| 2023-12-31 | $711,638 | 29,664 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $543,299 | 24,865 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $353,554 | 18,501 | Shares | Sole | 2023-08-15 | |
| 2023-03-31 | $322,050 | 16,592 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $257,939 | 16,081 | Shares | Sole | 2023-02-15 | |
| 2022-09-30 | $261,746 | 16,693 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $233,600 | 11,220 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $9,732,208 | 429,299 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $52,389,511 | 2,865,947 | Shares | Sole | 2022-02-09 | |
| 2021-09-30 | $58,942,442 | 2,788,195 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $37,197,915 | 2,041,598 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $46,761,006 | 2,069,987 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $29,394,642 | 1,464,606 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $28,723,028 | 1,174,766 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $25,527,170 | 1,075,281 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $5,358,622 | 311,186 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||